Literature DB >> 12049826

Deficient IgA and IgG2 anti-pneumococcal antibody levels and response to vaccination in otitis prone children.

Ingeborg J Dhooge1, Muriel J P van Kempen, Lieke A M Sanders, Ger T Rijkers.   

Abstract

OBJECTIVE: To evaluate the isotype and IgG subclass distribution of anti-pneumococcal antibodies and response to polysaccharide vaccination in otitis prone children.
METHODS: IgG1, IgG2 and IgA antibodies to pneumococcal serotypes 3, 4, 6B, 9V, 14, 19F and 23F were determined in otitis prone children and in an age-matched healthy control population. Patients were immunized with a 23-valent pneumococcal polysaccharide vaccine. The antibody response was measured 4 weeks later.
RESULTS: Geometric mean IgA and IgG2 antibody levels for all seven pneumococcal serotypes tested were significantly lower in otitis prone children than in the control population. After immunization, there was no significant increase in geometric mean IgG2 anti-serotype 6B, 19F and 23F pneumococcal polysaccharide (weak immunogenic), but also no increase for IgG2 anti-serotype 4 and 14. Post immunization IgG2 antibody titers for serotypes 6B, 9V and 19F even remained below titers of non-vaccinated controls. Nine out of 29 otitis prone children were colonized nasopharyngeally with Streptococcus pneumoniae during the time of vaccination; these children had an even more severely impaired systemic antibody response.
CONCLUSIONS: Otitis prone children, while having normal IgG1 antibody levels, have low IgG2 and IgA anti-polysaccharide antibody levels and fail to respond in these subclasses upon vaccination with pneumococcal polysaccharide vaccine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12049826     DOI: 10.1016/s0165-5876(02)00068-x

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  10 in total

1.  Association of CD14 promoter polymorphism with otitis media and pneumococcal vaccine responses.

Authors:  S P Wiertsema; S-K Khoo; G Baynam; R H Veenhoven; I A Laing; G A Zielhuis; G T Rijkers; J Goldblatt; P N Lesouëf; E A M Sanders
Journal:  Clin Vaccine Immunol       Date:  2006-08

2.  Pneumococcal conjugate vaccine followed by pneumococcal polysaccharide vaccine; immunogenicity in patients with ataxia-telangiectasia.

Authors:  A Stray-Pedersen; I S Aaberge; A Früh; T G Abrahamsen
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

Review 3.  Risk factors for the development of otitis media.

Authors:  Ingeborg J M Dhooge
Journal:  Curr Allergy Asthma Rep       Date:  2003-07       Impact factor: 4.806

4.  Immunogenicity and protective immunity against otitis media caused by pneumococcus in mice of Hib conjugate vaccine with PsaA protein carrier.

Authors:  Zeyu Chen; Rong Guo; Jianghong Xu; Chuangjun Qiu
Journal:  Front Med       Date:  2016-12-23       Impact factor: 4.592

5.  Optimal assessment of the ability of children with recurrent respiratory tract infections to produce anti-polysaccharide antibodies.

Authors:  D Tuerlinckx; F Vermeulen; V Pékus; G de Bilderling; Y Glupczynski; S Collet; J Jamart; E Bodart; F Mascart
Journal:  Clin Exp Immunol       Date:  2007-05-18       Impact factor: 4.330

Review 6.  Immunologic screening of children with recurrent otitis media.

Authors:  Selma P Wiertsema; Reinier H Veenhoven; Elisabeth A M Sanders; Ger T Rijkers
Journal:  Curr Allergy Asthma Rep       Date:  2005-07       Impact factor: 4.919

Review 7.  The differential impact of coadministered vaccines, geographic region, vaccine product and other covariates on pneumococcal conjugate vaccine immunogenicity.

Authors:  Daniel E Park; T Scott Johnson; Bareng Aletta S Nonyane; Subhash Chandir; Laura Conklin; Katherine E Fleming-Dutra; Jennifer D Loo; David Goldblatt; Cynthia G Whitney; Katherine L O'Brien; Maria Deloria Knoll
Journal:  Pediatr Infect Dis J       Date:  2014-01       Impact factor: 2.129

Review 8.  Assessment of disulfide and hinge modifications in monoclonal antibodies.

Authors:  Bernd Moritz; Jan Olaf Stracke
Journal:  Electrophoresis       Date:  2017-03-02       Impact factor: 3.535

9.  Reliability and validity of functional health status and health-related quality of life questionnaires in children with recurrent acute otitis media.

Authors:  Carole N M Brouwer; Anne G M Schilder; Henk F van Stel; Maroeska M Rovers; Reinier H Veenhoven; Diederick E Grobbee; Elisabeth A M Sanders; A Rianne Maillé
Journal:  Qual Life Res       Date:  2007-08-01       Impact factor: 4.147

10.  The Etiology, Pathophysiology, and Management of Otitis Media with Effusion.

Authors:  Christopher C. Butler; R. Gareth Williams
Journal:  Curr Infect Dis Rep       Date:  2003-06       Impact factor: 3.725

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.